Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.55), $0.13 better than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.